Research Focus
The Xu Group, led by Senior Group Leader Professor Zhi Ping (Gordon) Xu, is a multidisciplinary research team with strengths in the controlled preparation of anionic clay nanomaterials and several other nanomaterials for diverse applications spanning drug, gene and protein delivery, vaccinations and imaging.
The Group is developing a fundamental understanding of the interactions of clay-drug nanoparticles with proteins in serum and target cells, while also building knowledge of the subsequent biological effects. This understanding enables the design and synthesis of improved nanomaterials for a range of applications, including drug delivery, gene delivery, protein delivery, vaccine adjuvants and bioimaging.
Group members and key collaborators cover a range of disciplines including nanomaterials science and technology, colloidal chemistry, cellular and molecular biology, biomedicine, biosensor, immunology and neuroscience.
News
-
-
Federal funding supports important health research
30 August 2019 -
Clay nanoparticles could give vaccines a boost
4 July 2018